Intravenous immunoglobulin manufactured from selected Chinese donors protects mice from lethal Enterovirus 71 infection  by Cao, R. et al.
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nd drug resistance. Our aim was to characterize by full
equence BCG Mexico 1931 for using in the new develop
accine.
Methods: The sequence of BCG Mexico 1931 was per-
ormed with 2X pyrosequencing method. BCG Mexico 1931
enetic proﬁle was performed by multiplex PCR and PFGE.
he multiplex PCR was performed to detect RD and DU
egions in strains. The reference BCG strains used in this
tudy were Pasteur 1173P2, Phipps, Tice and Danish 1331.
Results: The circular chromosome at 99.8% coverage of
CG Mexico 1931 was 4 350 386-bp, its analyses conﬁrm the
D1, RD2, nRD18 absence and the presence of duplication
U2 group IV described by multiplex PCR. The comparison of
CG Pasteur1173P2 genome sequence with BCG Mexico 1931
howed differences between strains, including the presence
f RD14, SNPs and the absence of DU1. In addition, three
ew RD regions of 53, 655 and 2847 bp were uncovered. The
omparison of proﬁles obtained by PCR multiplex showed
hat BCG Mexico 1931 proﬁle was identical to BCG Phipps
nd Tice, with the lost of RD1, RD2, nRD18 and presence of
U2 group IV. PFGE was performed with AsnI/DraI enzymes,
he analyses detected 18/12 fragments in BCG Danish 1331
nd Mexico 1931, 17/12 in Pasteur 1173P2, 15/10 in Phipps
nd 14/10 in Tice, respectively. Interesting, the restriction
attern with AsnI showed the presence of 220 kb fragment
nly in BCG Mexico, Tice and Phipps.
Conclusion: The BCG Mexico 1931 showed a close rela-
ion with BCG Phipps and Tice, strains situated into group IV
rom genealogy of BCG vaccines. However, in diverse studies
hese strains shown differences on the induction of immune
esponse.
oi:10.1016/j.ijid.2010.02.630
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neumococcal vaccination - is hyporesponsiveness a prob-
em?
. Lode
RCMS, Berlin, Germany
Background: Several studues in the past have
emostrated that the pneumococcal polysaccharide
accine (PPV 23) will induce hyporesponsiveness in vacci-
ated patients over a long time period. The duration of
his effect and the impactv on a second vaccination with
conjugated vaccine (PCV 13) after at least 3 years is not
nown.
Methods: To address these open questions we investi-
ated 55 persons (30 males, age between 68 and 87 years),
ho had a ﬁrst PPV 23 - vaccination 3 - 8 years before
nd received a second vaccination with PCV 13. Immedi-
tely before and 4 - 6 weeks after PCV 13 vaccination
lood specimen were taken and antibodies to 13 individ-
al poysaccharides (1,3,4,5,6A,6B,7F,9 V,14,18,19A,19F,25F)
ere determined by a validated enzyme-linked immunosor-
ent assay.
Results: 3 - 8 years after PPV 23 vaccination antibody
oncentrations were low but in 11 out of 13 serotypes still
bove 1,0 !g/ml (the assumed protection level for adults);
nly serotypes 3 and 23F had mean concentrations (+/- SD)
f 0,66+/- 0,38 !g/ml and 0,57+/- 0.39 !g/ml. 4 - 6 weeks
h
t
T
iternational Congress on Infectious Diseases (ICID) Abstracts
fter vaccination with PCV 13 all serotypes showed an signif-
cant increase in antibody concentrations; however, a great
esponse variability between the different serotypes was
easured with small antibody increases in serotype 3 and
igh concentrations in serotypes 4, 5,7F,19A and 19F.The
olerance of vaccination with PCV 13 was excellent.
Conclusion: The results of this study demonstrate that
ﬁrst PPV 23 vaccination has only limited impact on a
econd vaccination with a new conjugated pneumococcal
accine(PVP13) 3 - 8 years later. Hyporesponsiveness was
ot a major problem in this study. However, these results
ave to be conﬁrmed in a study with a greater number of
lderly patients.
oi:10.1016/j.ijid.2010.02.631
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ntravenous immunoglobulin manufactured from selected
hinese donors protects mice from lethal Enterovirus 71
nfection
. Cao, J. Han, E. Qin, C. Qin ∗
Beijing Institute of Microbiology and Epidemiology, Beijing,
hina
Background: Enterovirus 71 (EV71) has emerged as a
igniﬁcant cause of acute encephalitis and paralysis in
hina, resulting in hundreds of deaths in young children
ince 2006. Passive transfer of intravenous immunoglobu-
in (IVIG) from Chinese donors has been associated with
educed mortality in children with severe EV71 infec-
ions. The anti-EV71 neutralization antibodies in Chinese
VIG products may contribute to the protection from EV71
nfection.
Methods: A modiﬁed high-throughput microneutraliza-
ion assay was performed to screen for plasma units
ontaining high titer (>100) anti-EV71 antibodies from Chi-
ese plasma donors. Positive units were then pooled and
rocessed into pharmaceutical grade EV71-speciﬁc IVIG
EV71-IVIG). Different doses (0.1 to 5mg) of EV71-IVIG and
ommercial IVIG were administered following lethal EV71
nfection in sucking mice, respectively, according to the spe-
iﬁc experimental protocol. Mice were monitored daily for
ody weight and mortality.
Results: About 10% of the plasma units from Chinese
lasma donors were selected to produce EV71-IVIG. In vitro
eutralization assays showed that the anti-EV71 antibod-
es titer (>1024) in EV71-IVIG preparations was 10-fold
igher than that in commercial IVIG preparations. Full
rotection was archived when the infected mice were
reated with EV71-IVIG, while similar treatments using com-
ercial IVIG had no protective effect. Recovery of the
nfected mice was dependent on the dose and time of IVIG
dministration.Conclusion: These results demonstrated that IVIG with
igher titer (>1024) neutralization antibodies conferred pro-
ection against lethal EV71 challenge in an animal model.
his ﬁnding also suggested that blood from selected donors
n EV71 endemic regions can improve the potency of IVIG and
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EV71-IVIG should be developed for the treatment of fatal
EV71 infections.
doi:10.1016/j.ijid.2010.02.632
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Polio controling Nigeria and other developing countries:
A systematic review/meta-analysi of literature on the use
of combined OPV & IPV measure as against OPV only
S.I. Ezikeanyi
Federal Ministry of Health Abuja, ABUJA, Nigeria
Background: Despite the overwhelming evidence-based
studies across the world on the efﬁcacy and effectiveness
of poliomyelitis eradication using the combined OPV & IPV
immunization schedule for children 0-59 months, Nigeria
still adheres to her policy on monovalent ‘Sabin’ live atten-
uated oral polio vaccine (mOPV1) that is only targeting
the type 1 strain among the three strains of the virus.
The question here is what informs Nigeria health policy
makers’ decision to continue with the current policy that
started since 2006 despite the persistent circulating Wild
Polio Virus (WPV) that has had its toll on children and drains
all efforts of achieving the MDGs 4 of reducing Child mor-
bidity and mortality come 2015. Empirical evidence from
a number of countries suggests that a policy on combined
Sabin live attenuated oral polio vaccine (OPV) and Salk killed
inactivated polio vaccine (IPV) in polio control program by
improving protection of children at individual levels and
at community level by conferring herd immunity can make
a major contribution to poliomyelitis control and possible
eradication of the persistent circulating wild polio strain and
its consequent disability and mortality.
Methods: A systematic literature review methodology
was used to identify relevant publications that reported the
use of OPV & IPV in the control of polio. Databases were
searched using different search terms. Of the 100 publica-
tions initially selected, 38 met the inclusion criteria and had
evidence level 1 and 2 ranking.
Results: The research revealed a remarkable reduction
in polio incidence in those countries. OPV & IPV was found
to reduce polio incidence or outbreak by 85%-90%, Acute
Flaccid Paralysis (AFP) by 85% and cost per child of 5$ for
full immunization coverage.
Conclusion: OPV & IPV combination has been shown to
be more effective than OPV alone and very potent in the
eradication of persistent strains of the virus. The author rec-
ommends the adoption of OPV & IPV by Nigeria as the main
dynamics of driving the polio immunization program towards
elimination or even total eradication of the wild circulat-
ing polio virus in Nigeria and other neighboring sub-Saharan
African countries.
doi:10.1016/j.ijid.2010.02.633
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actors associated with outbreaks of measles in the
ighly immunized hilly areas of district Kangra, Himachal
radesh, India, 2007
.N. Gupta1,∗, V. ramachandran2, N.N. Gupta3, M.D.
upte2
Regional Health and Family Welfare Traiing Centre, Chheb,
angra, Kangra, Himachal Pradesh, India
National Institute of Epidemiology, Indian Council of Med-
cal Research, Chennai, Tamilnadu, Tamilnadu, India
Free lance researcher in Epidemiology, Kangra, Himachal
radesh, India
Background: Measles is the ﬁfth killer disease among chil-
ren under ﬁve years in the world. In Indian states, we are
n the heterogeneity of measles vaccination. In Himachal
radesh, despite high immunization coverage, the outbreaks
re occurring. Based upon two outbreaks, we conducted a
ase control study to identify factors associated with out-
reaks of measles and to recommend appropriate remedial
easures to prevent further outbreaks.
Methods: We reviewed the factors under three heads:
rogramme related, health care providers and beneﬁcia-
ies related. We used case-deﬁnition of measles adapted
y the WHO. We enrolled all 69 mothers of children with
easles. Controls were matched for age and sex. We used
pre-designed pre-tested data collection instrument. We
alculated the odds ratio and adjusted odds ratio with 95%
onﬁdence Interval (C.I.) among women of children exposed
nd unexposed to selected characteristics.
Results: Only beneﬁciary related issues were associ-
ted with outbreaks in case area which were indicated
y Focus Group Discussions and further conﬁrmed dur-
ng in-depth interviews in quantitative univariate analysis
ielding statistical signiﬁcance. Important socio-economic
ariables are Educational Status yielding to OR 27.63 (95%
.I. 9.46-85.16); Occupation with OR 0.35 (95% C.I. 0.16-
.75); Income with OR 5.49 (95% C.I. 2.36-13.00); mode of
ransport to the health care facility; OR 8.74 (95% C.I. 2.90-
8.23); First help contact when the child falls ill OR 2.12
95% C.I. 1.00-4.50). Knowledge about the child illness in the
amily, OR 5.03 (95% C.I. 0.95-35.17); Spread of illness from
ne person to other person OR 5.60 (95% C.I. 1.40-25.97)
nd Person for treatment, OR 2.85 (95 C.I. 1.27-6.46); Place
f visit after recovery from the measles, OR 3.92 (95% C.I.
.80-8.63). Multiple Logistic Regression yielded the signif-
cant variable as-educational status with AOR 438.72 (95%
.I. 17.0-11272.16).
Conclusion: Measles outbreaks were conﬁrmed in high
mmunization coverage areas. We recommend (i) 2nd dose
pportunity for measles (MMR) between 5 to 17 years; (ii)
mproving access to health care facility and (iii) IEC activi-
ies for social behavioral change rather than informing the
ommunity.
oi:10.1016/j.ijid.2010.02.634
